Fingerprint
Dive into the research topics of 'MAHOGANY: Margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
MAHOGANY: Margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma
Daniel V.T. Catenacci, Minori Rosales, Hyun Cheol Chung, Harry H. Yoon, Lin Shen, Markus Moehler, Yoon Koo Kang
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations